[1]沈孟杰.氟喹诺酮类药物临床应用的不良反应与用药原则研究[J].医学信息,2018,31(15):135-136.[doi:10.3969/j.issn.1006-1959.2018.15.043]
 SHEN Meng-jie.Adverse Reactions and Principles of Drug Use in Clinical Application of Fluoroquinolones[J].Journal of Medical Information,2018,31(15):135-136.[doi:10.3969/j.issn.1006-1959.2018.15.043]
点击复制

氟喹诺酮类药物临床应用的不良反应与用药原则研究()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
31卷
期数:
2018年15期
页码:
135-136
栏目:
药物与临床
出版日期:
2018-08-01

文章信息/Info

Title:
Adverse Reactions and Principles of Drug Use in Clinical Application of Fluoroquinolones
文章编号:
1006-1959(2018)15-0135-02
作者:
沈孟杰
天津市第三中心医院分院药剂科,天津 300250
Author(s):
SHEN Meng-jie
Department of Pharmacy,Tianjin Third Central Hospital Branch,Tianjin 300250,China
关键词:
氟喹诺酮类药物不良反应用药原则
Keywords:
Key words:FluoroquinolonesAdverse reactionsPrinciples of drug use
分类号:
R978.19
DOI:
10.3969/j.issn.1006-1959.2018.15.043
文献标志码:
A
摘要:
目的 探讨氟喹诺酮类药物在临床应用中的不良反应以及用药原则。方法 选取本院2016年2月~2017年3月使用氟喹诺酮类药物出现不良反应的70例患者,分析所有患者使用的药品种类以及不良反应发生情况。结果 在所有氟喹诺酮类药物使用中,不良反应发生率最高的药物为环丙沙星,占41.18%;其次为加替沙星,占29.41%;而在不良反应发生情况中,胃肠系统不良反应发生率最高,占50.94%;其次为皮肤,占45.59%。结论 在使用氟喹诺酮类药物的过程中,需要注重药物的不良反应,根据患者的实际情况选择合适的药物,以此来降低不良反应的发生率。
Abstract:
Abstract:Objective To investigate the adverse reactions and principles of drug use fluoroquinolones in clinical application.Methods From February 2016 to March 2017,70 patients with adverse reactions of fluoroquinolones were selected and the types of drugs used and the occurrence of adverse reactions were analyzed.Results In the use of all fluoroquinolones,ciprofloxacin was the highest rate of adverse drug reactions accounting for 41.18%,followed by gatifloxacin,accounting for 29.41%.The incidence of adverse reactions in gastrointestinal system was the highest accounting for 50.94%,followed by skin accounting for 45.59%.Conclusion In the course of using fluoroquinolones,we should pay attention to the adverse reactions of the drugs and choose the appropriate drugs according to the actual situation of the patients,so as to reduce the incidence of adverse reactions.

参考文献/References:

[1]蔺以啟.氟喹诺酮类药物临床应用的不良反应与用药原则[J].中国医药科学,2015,2(01):102-103,105.
[2]李玉萍.氟喹诺酮类药物临床应用中的不良反应及合理应用原则[J].中国民族民间医药,2016,21(16):53.
[3]刘文慧.氟喹诺酮类药物的临床用药原则和相关不良反应探讨[J].中国医药导刊,2016,14(10):1791-1792.
[4]胡逸微.喹诺酮类药物临床应用中的不良反应研究[J].世界最新医学信息文摘,2018,18(30):109,111.
[5]王明明,李海涛.药学干预在喹诺酮类药物临床合理应用中的效果分析[J].临床医学研究与实践,2017,2(36):50-51.
[6]米荣峥,冯伟.探讨喹诺酮类药物临床不良反应及安全用药[J].世界最新医学信息文摘,2017,17(06):106,109.

相似文献/References:

[1]董荣长.蓝光治疗新生儿黄疸的效果研究[J].医学信息,2018,31(01):116.[doi:10.3969/j.issn.1006-1959.2018.01.044]
 DONG Rong-chang.Study on the Effect of Blue Light in the Treatment of Neonatal Jaundice[J].Journal of Medical Information,2018,31(15):116.[doi:10.3969/j.issn.1006-1959.2018.01.044]
[2]鲁从林,王先丹,杨遂平,等.奥氮平治疗老年痴呆伴精神行为障碍的临床疗效观察[J].医学信息,2018,31(01):138.[doi:10.3969/j.issn.1006-1959.2018.01.053]
 LU Cong-lin,WANG Xian-dan,YANG Sui-ping,et al.The Clinical Efficacy of Olanzapine in the Treatment of Alzheimer's Disease with Mental Behavior Disorder[J].Journal of Medical Information,2018,31(15):138.[doi:10.3969/j.issn.1006-1959.2018.01.053]
[3]邱君旗.幽门螺杆菌根除治疗对幽门螺杆菌阳性的功能性消化不良患者疗效分析[J].医学信息,2018,31(04):75.[doi:10.3969/j.issn.1006-1959.2018.04.024]
 QIU Jun-qi.Efficacy of Helicobacter Pylori Eradication Therapy in Patients with HP Positive Functional Dyspepsia[J].Journal of Medical Information,2018,31(15):75.[doi:10.3969/j.issn.1006-1959.2018.04.024]
[4]王国富.舒尼替尼用于治疗晚期肾细胞癌的临床分析[J].医学信息,2018,31(06):128.[doi:10.3969/j.issn.1006-1959.2018.06.043]
 WANG Guo-fu.Clinical Analysis of Sunitinib in the Treatment of Advanced Renal Cell Carcinoma[J].Journal of Medical Information,2018,31(15):128.[doi:10.3969/j.issn.1006-1959.2018.06.043]
[5]柳 梅.头孢哌酮钠舒巴坦钠治疗糖尿病并发尿路感染的 临床效果观察[J].医学信息,2018,31(07):139.[doi:10.3969/j.issn.1006-1959.2018.07.047]
 LIU Mei.Clinical Efficacy of Cefoperazone Sodium and Sulbactam Sodium in Treatment of Diabetes Complicated with Urinary Tract Infection[J].Journal of Medical Information,2018,31(15):139.[doi:10.3969/j.issn.1006-1959.2018.07.047]
[6]孙 阳,秦玉梅.头孢菌素类药物常见不良反应产生原因及护理应用对策研究[J].医学信息,2018,31(08):176.[doi:10.3969/j.issn.1006-1959.2018.08.064]
 SUN Yang,QIN Yu-mei.Causes of Common Side Effects of Cephalosporins and Countermeasures for Nursing Application[J].Journal of Medical Information,2018,31(15):176.[doi:10.3969/j.issn.1006-1959.2018.08.064]
[7]杨 凯.高效抗逆转录病毒治疗艾滋病的临床疗效观察[J].医学信息,2018,31(08):178.[doi:10.3969/j.issn.1006-1959.2018.08.065]
 YANG Kai.Clinical Observation on the Effect of Highly Effective Antiretroviral Therapy on AIDS[J].Journal of Medical Information,2018,31(15):178.[doi:10.3969/j.issn.1006-1959.2018.08.065]
[8]冯彩云.胺碘酮导致间质性肺病患者的1例分析[J].医学信息,2018,31(10):191.[doi:10.3969/j.issn.1006-1959.2018.10.068]
[9]沈孟杰.注射用头孢哌酮钠舒巴坦钠临床应用效果及 不良反应发生情况研究[J].医学信息,2018,31(12):131.[doi:10.3969/j.issn.1006-1959.2018.12.040]
 SHEN Meng-jie.Clinical Application and Adverse Reactions of Cefoperazone Sodium and Sulbactam Sodium for Injection[J].Journal of Medical Information,2018,31(15):131.[doi:10.3969/j.issn.1006-1959.2018.12.040]
[10]庞小坤,韩 梅,江心灿,等.当归补血汤治疗肿瘤化疗不良反应随机对照临床试验的Meta分析[J].医学信息,2019,32(02):69.[doi:10.3969/j.issn.1006-1959.2019.02.021]
 Pang Xiao-kun,Han Mei,Jiang Xin-can,et al.Meta-analysis of a Randomized Controlled Clinical Trial of Angelica Buxue Decoction in the Treatment of Adverse Reactions to Chemotherapy[J].Journal of Medical Information,2019,32(15):69.[doi:10.3969/j.issn.1006-1959.2019.02.021]
[11]陈 勐.氟喹诺酮类药物的禁忌证、不良反应及临床合理用药对策[J].医学信息,2018,31(19):145.[doi:10.3969/j.issn.1006-1959.2018.19.044]
 CHEN Meng.Contraindications and Adverse Reactions of Fluoroquinolones and their Countermeasures for Rational Use of Drugs in Clinical[J].Journal of Medical Information,2018,31(15):145.[doi:10.3969/j.issn.1006-1959.2018.19.044]

更新日期/Last Update: 2018-08-01